J&J, Angiotech Reach Accord Over Stent Patents
By Ron Zapata · September 17, 2007, 12:00 AM EDT
Johnson & Johnson subsidiary Conor Medsystems has reached a settlement with Angiotech Pharmaceuticals Inc. to resolve litigation regarding drug-eluting stents used in cancer chemotherapy....
To view the full article, register now.